Basket Study for Oligo-metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Trastuzumab deruxtecan
Sponsor: The Netherlands Cancer Institute
Collaborators: Daiichi Sankyo|AstraZeneca